8 www.herba.sk Štandardný diagnosticko-terapeutický postup Edícia: Odborné odporúčania pre klinickú prax Metodické listy racionálnej farmakoterapie Redakčná rada Jozef Holomáň – vedúci redaktor Ján Bielik, Viliam Foltán, Ján Gajdošík, Jozef Glasa, Ľubomír Jurgoš, Gustav Kováč, Milan Lehký, Ľubica Slobodová, Dominik Tomek Andrea Nýblová – výkonná redaktorka SZU, Limbová 12, 833 03 Bratislava, tel.: 02/59370 838, 02/59370 796, e-mail: jozef.holoman@szu.sk Vydáva Zdravotnícke vydavateľstvo HERBA, spol. s r. o., IČO 31 390 421, Bárdošova 3, 831 01 Bratislava, EV 5517/17, tel.: 02/5477 6683, www.herba.sk, občasník with diarrhea, American Journal of Gastroenterology, 2019, s. 1886–1893. 23. Domanski J.P. et al.: Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review, Nutrients 2022, Vol. 14, Page 3382, 2022, s. 3382. 24. LowK. et al.: A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test, J Clin Gastroenterol, 2010, s. 547–550. 25. García-Collinot G. et al.: Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis, Dig Dis Sci, 2020, s. 1134–1143. 26. Kumar K. et al.: Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth, Dig Dis Sci, 2018, s. 989–995. 27. Wielgosz-Grochowska J.P. et al.: Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review, Nutrients, 2022, s.3382. 28. Zhong C. et al.: Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence, J Clin Gastroenterol, 2017, s. 300–311. 29. Madrid A.M. et al.: Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function, Am J Gastroenterol, 2001, s. 1251–1255. 30. Adike A., DiBaise J.K.: Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, andManagement, Gastroenterol Clin North Am, 2018, s. 193–208. 31. Souza C. et al.: Diet and intestinal bacterial overgrowth: Is there evidence?, World J Clin Cases, 2022, s. 4713–4716. 32. Lai P.K., Roy J.: Antimicrobial and chemopreventive properties of herbs and spices, Curr Med Chem, 2004, s. 1451–1460. 33. Chedid V. et al.: Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth, Glob Adv Health Med, 2014, s. 16–24. 34. Nickles M.A. et al.: Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review, J Altern Complement Med, 2021, s. 108–119. 35. Park J.H.: Clinical Usefulness of FecalMicrobiotaTransplantation, J Neurogastroenterol Motil, 2017. s. 149–150. 36. Xu F. et al.: Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study, BMC Gastroenterology, 2021. s. 54. Autori MUDr. Marian Oltman, PhD. Ing. Jarmila Kabátová MUDr. Radovan Juríček MUDr. Peter Lipták Oponenti MUDr. Sylvia Dražilová, PhD. MUDr. Tatiana Novotná, PhD.
RkJQdWJsaXNoZXIy MTYxNjU3OA==